Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Manal F. Abdelmalek"'
Autor:
Mary E. Rinella, Brent A. Neuschwander-Tetri, Mohammad Shadab Siddiqui, Manal F. Abdelmalek, Stephen Caldwell, Diana Barb, David E. Kleiner, Rohit Loomba
Publikováno v:
Hepatology (Baltimore, Md.), vol 77, iss 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4fcbc694dffb3cda6c4da05630b6411
https://escholarship.org/uc/item/9cn5c5jr
https://escholarship.org/uc/item/9cn5c5jr
Autor:
Andrea G. Nackley, Wolfgang Liedtke, Anna Mae Diehl, Huiping Ding, Andreas E. Kremer, Johannes Morstein, Ana E. López-Romero, Qian Zeng, Zilong Wang, Ru-Rong Ji, Qiaojuan Zhang, Yong Chen, Xin Zhang, Piotr Milkiewicz, Tony E. Reeves, Sara L. Morales-Lázaro, Jennifer Y. Zhang, Marcin Krawczyk, Tamara Rosenbaum, Mei-Chuan Ko, Frank Lammert, Andrey V. Bortsov, Manal F. Abdelmalek, Michele Yeo, Huanghe Yang, Carlene Moore, Ying-Ai Jin
Publikováno v:
Gastroenterology. 161(1)
Background & Aims Limited understanding of pruritus mechanisms in cholestatic liver diseases hinders development of antipruritic treatments. Previous studies implicated lysophosphatidic acid (LPA) as a potential mediator of cholestatic pruritus. Meth
Autor:
Francesco Negro, Keith D. Lindor, Kris V. Kowdley, Michael Charlton, Manal F. Abdelmalek, Stephen H. Caldwell, Elisabetta Bugianesi, Quentin M. Anstee, V. Ratziu, Zobair M. Younossi, Brent A. Neuschwander-Tetri, Stephen A. Harrison, Rohit Loomba, Jacob George, Scott L. Friedman, Kathleen E. Corey, Philippe Mathurin, Joel E. Lavine, A. Sanyal, Zachary Goodman, Lawrence Serfaty, Giulio Marchesini, Mary E. Rinella, N. Chalasani
Publikováno v:
Hepatology (Baltimore, Md.), vol 68, iss 1
Nonalcoholic fatty liver disease (NAFLD) is a spectrum comprised of isolated steatosis, nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. The majority of NAFLD subjects do not have NASH and do not carry a significant risk for liv
Autor:
Zobair M. Younossi, Keith D. Lindor, Scott L. Friedman, Mary E. Rinella, Stephen H. Caldwell, Giulio Marchesini, Philippe Mathurin, Naga Chalasani, Rohit Loomba, Elisabetta Bugianesi, Brent A. Neuschwander-Tetri, Jacob George, Stephen A. Harrison, Lawrence Serfaty, Manal F. Abdelmalek, Zachary Goodman, Kathleen E. Corey, Arun J. Sanyal, Francesco Negro, Michael Charlton, Vlad Ratziu, Joel E. Lavine, Kris V. Kowdley, Quentin M. Anstee
Publikováno v:
Hepatology (Baltimore, Md.), vol 68, iss 1
Nonalcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH), are rapidly becoming among the top causes of cirrhosis, hepatocellular carcinoma, and indications for liver transplantation. Other than lifestyle
Autor:
Brian L. Wiens, Jeffrey Vest, Guruprasad P. Aithal, Arun J. Sanyal, Star Seyedkazemi, Vincent Wai-Sun Wong, Zachary Goodman, Laurent Fischer, Rohit Loomba, Eric Lefebvre, Vlad Ratziu, Frank Tacke, Kris V. Kowdley, Geoffrey C. Farrell, Manal F. Abdelmalek, Pamela Vig, Liza Melchor-Khan, Antonio Craxì, Scott L. Friedman, Krzysztof Simon, Juan Caballería, Stephen A. Harrison, Sven Francque
Publikováno v:
Hepatology (Baltimore, Md.), vol 67, iss 5
Hepatology
Hepatology (Baltimore, Md.)
Hepatology
Hepatology (Baltimore, Md.)
The aim of this study was to evaluate cenicriviroc (CVC), a dual antagonist of C-C chemokine receptor types 2 and 5, for treatment of nonalcoholic steatohepatitis (NASH) with liver fibrosis. A randomized, double-blind, multinational phase 2b study en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd279267e63b246d0eb39c5941a3a85b
https://nottingham-repository.worktribe.com/file/927093/1/Friedman_et_al-2018-Hepatology.pdf
https://nottingham-repository.worktribe.com/file/927093/1/Friedman_et_al-2018-Hepatology.pdf
Autor:
Sam Galhenage, Manal F. Abdelmalek
Publikováno v:
Current Hepatitis Reports. 6:39-45
Alcohol consumption and hepatic steatosis interact synergistically with hepatitis C virus (HCV) to accelerate fibrosis progression and reduce the efficacy of standard antiviral therapies. Research aimed at delineating the viral and host interactions
Autor:
Gary L. Davis, Alan W. Hemming, Manal F. Abdelmalek, Consuelo Soldevila-Pico, David R. Nelson, Roberto J. Firpi, Chen Liu, James M. Crawford, Alan I. Reed
Publikováno v:
Liver Transplantation. 10:199-207
Recurrent hepatitis C infection is an important cause of progressive fibrosis, cirrhosis, and graft loss following orthotopic liver transplantation. Treatment for posttransplant recurrence of hepatitis C with interferon-based therapy is difficult but
Autor:
Gary L. Davis, Chen Liu, Alan W. Hemming, Alan I. Reed, Roberto J. Firpi, Gregory Y. Lauwers, James M. Crawford, William van der Werf, Consuelo Soldevila-Pico, David R. Nelson, Manal F. Abdelmalek, Richard J. Howard
Publikováno v:
Liver Transplantation. 8:1000-1006
Recurrent hepatitis C virus (HCV) infection is an important cause of fibrosis and cirrhosis after liver transplantation (LT), with histological recurrence developing in at least 50% of patients within the first year. The aim of this study is to asses
Publikováno v:
Arthritis & Rheumatism. 42:812-817
We describe 2 patients presenting with polyarthritis in whom the synovial fluid (1 patient) or synovial tissue (1 patient) was positive for Tropheryma whippelii, the Whipple's disease-associated bacillus, when examined by polymerase chain reaction (P
Publikováno v:
Hepatology. 61:1770-1771
We agree that nuclear localization of Gli2 protein can result from both canonical and non-canonical Hedgehog signaling. Our most recent study examined correlations between the severity of NASH and Hedgehog signaling activity in patients enrolled in t